RE:Roche reports Q3 earnings - looks to Tecentriq for future London, UK and Boston, MA – 18 October 2022: The global pharmaceutical industry is set to see sales grow by an annualised 6% between 2022 and 2028, according to the latest World Preview published by Evaluate Ltd. The annual report, which details the future of the biopharmaceutical sector, forecasts industry revenues of $1.6 Trillion in six years’ time.
Leading this market will be Roche, currently the fifth largest player in the market, with $62.7 Billion of forecast sales in 2028, accounting for 3.9% of the worldwide market.
AbbVie is seen closely behind with prescription sales of $62 Billion that year.
The fastest growing big pharma player will be AstraZeneca, according to Evaluate, whose top-line is predicted to expand by 5.8% year on year, to 2028.